Cargando…
Synthesis, Antitumor Activity, and In Silico Drug Design of New Thieno[2,3-d]Pyrimidine-4-One Derivatives as Nonclassical Lipophilic Dihydrofolate Reductase Inhibitors
[Image: see text] Synthesis of a new series of 20 compounds bearing the thieno[2,3-d]pyrimidine-4-one scaffold was achieved. The inhibitory activity of these compounds was performed over 60 cell lines of human tumor at single and five dose concentrations. Compounds 20, 22, and 23 exhibited potent gr...
Autores principales: | Abdelaziz, Ola A., El Husseiny, Walaa M., Selim, Khalid B., Eisa, Hassan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9753513/ https://www.ncbi.nlm.nih.gov/pubmed/36530275 http://dx.doi.org/10.1021/acsomega.2c06078 |
Ejemplares similares
-
Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors
por: Wróbel, Agnieszka, et al.
Publicado: (2019) -
Tales of Dihydrofolate Binding to R67 Dihydrofolate
Reductase
por: Duff, Michael R., et al.
Publicado: (2015) -
In Silico Study Probes Potential Inhibitors of Human Dihydrofolate Reductase for Cancer Therapeutics
por: Rana, Rabia Mukhtar, et al.
Publicado: (2019) -
Synthesis, Characterization and Biological Studies of Some Novel Thieno[2,3-d]pyrimidines
por: Al-Taisan, Khulud M., et al.
Publicado: (2010) -
Adaptations for Pressure and Temperature in Dihydrofolate Reductases
por: Penhallurick, Ryan W., et al.
Publicado: (2021)